Kura oncology address
WebJul 24, 2024 · SAN DIEGO, July 24, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. ... (IND) application in March 2024 and recognizes the potential for KO-539 to address a high unmet need for patients suffering from AML. We are very encouraged by our preclinical data in genetically defined subsets, such as tumors with MLL fusions and rearrangements and … WebJan 24, 2024 · SAN DIEGO, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the...
Kura oncology address
Did you know?
WebSpecialties: Kura Sushi USA, Inc., is an innovative and tech interactive Japanese restaurant concept established in 2008 as a subsidiary of Kura Sushi, Inc. As pioneers of the … WebOct 18, 2024 · SAN DIEGO, Oct. 18, 2024(GLOBE NEWSWIRE) -- Kura Oncology, Inc.(Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced the appointment of Teresa Bairas Chief Legal Officer and Corporate Secretary. Ms.
WebApr 15, 2024 · Kura Oncology Stock Down 3.2 % Shares of Kura Oncology stock opened at $11.44 on Friday. The stock has a market capitalization of $782.94 million, a price-to … WebOct 18, 2024 · Kura Oncology, Inc. 12730 High Bluff Drive, Suite 400 San Diego, CA 92130 (858) 500-8800 Kura Oncology, Inc. 2 Seaport Lane, Suite 8A Boston, MA 02210 (617) 588 …
WebAug 5, 2024 · SAN DIEGO, Aug. 05, 2024(GLOBE NEWSWIRE) -- Kura Oncology, Inc.(Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today reported second quarter 2024 financial results and provided a corporate update. WebNov 24, 2024 · The US Food and Drug Administration (FDA) has placed a partial clinical hold on Kura Oncology’s Phase Ib KOMET-001 clinical trial of its drug candidate, KO-539, in relapsed or refractory acute myeloid leukaemia (AML) patients. KO-539 is a potent and selective inhibitor of menin. The FDA’s partial clinical hold comes in response to the ...
WebJan 20, 2024 · Contacts Company: Pete De Spain Vice President, Investor Relations & Corporate Communications (858) 500-8803 [email protected] Investors: Robert H. Uhl Managing Director Westwicke ICR (858) 356-5932 [email protected] Media: Jason Spark Managing Director Canale Communications (619) 849-6005 …
WebKura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. Our small-molecule drug … by hours usaquenWebJun 7, 2024 · Kura Oncology, Inc. Aug 2014 - Present8 years 9 months La Jolla, California and Cambridge, Massachusetts Wellspring Biosciences … byhouse architectsWebApr 11, 2024 · KURA News Today Why did Kura Oncology stock go down today? NASDAQ:KURA Kura Oncology - KURA News Today $12.31 -0.04 (-0.32%) (As of 03/29/2024 12:00 AM ET) Compare Today's Range $11.90 $12.52 50-Day Range $10.71 $14.60 52-Week Range $10.30 $19.93 Volume 828,678 shs Average Volume 667,804 shs Market … byhouseWeb1 day ago · Kura Oncology (KURA) Looks Good: Stock Adds 6.8% in Session 08/26/20-7:31AM EST Zacks. Other News for KURA SVB Securities Sticks to Its Buy Rating for Kura Oncology (KURA) 03/28/23-5:06AM EST TipRanks by hours mannheimWebDec 13, 2024 · SAN DIEGO, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the... by houston llcWebApr 6, 2024 · View Kura Oncology, Inc KURA investment & stock information. Get the latest Kura Oncology, Inc KURA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. byhours granollersWeb1 day ago · Kura Oncology (KURA) Looks Good: Stock Adds 6.8% in Session 08/26/20-7:31AM EST Zacks. Other News for KURA SVB Securities Sticks to Its Buy Rating for Kura Oncology (KURA) 03/28/23-5:06AM EST TipRanks by hour鍜宐y the hour